Your Sorted CME/CE Activities


Quarterly Brief (July-Sept 2019): A Current Expert Analysis on Important HIV Clinical Decisions
Certified CME/CNE/CPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from July through September, 2019, will discuss recent data on HIV treatment considerations, complications, and future treatment options.

Review the Quarterly Brief and claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of the brief Post-Test/Evaluation.








Ask the Expert
Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical Center
Faculty
 Charles W. Flexner, MD Charles W. Flexner, MD
Professor of Medicine
Pharmacology and Molecular Sciences and International Health
Chief Scientific Officer, Institute for Clinical and Translational Research
Johns Hopkins University

20
Supported by an independent educational grant from Viiv Healthcare.
September 30, 2020
Mini Module
6441
QuarterlyBrief_WebBanner_1158.gif
HIV